Harm Reduct J. 2026 Jun 17. doi: 10.1186/s12954-026-01486-y. Online ahead of print. ABSTRACT BACKGROUND: As xylazine-adulterated opioids become more prevalent in the U.S., people who use drugs (PWUD) face growing risks from sedation, withdrawal, and wounds. This study explores PWUD perceptions on recognizing xylazine exposure including its physical effects and clinical harms and how these […]